Related Experiment Video
Updated: Jul 17, 2025
13:00
Low Molecular Weight Protein Enrichment on Mesoporous Silica Thin Films for Biomarker Discovery
Published on: April 17, 2012
13.5K
Zwitterionic mesoporous engineering aids peptide-dependent pattern profiling for identification of different liver
Zixing Xu1, Wantong Zhang1, Chunhui Deng1,2
1Department of Gastroenterology and Hepatology, Zhongshan Hospital, and Department of Chemistry, Fudan University, Shanghai, 200433, China.
Chemical Communications (Cambridge, England)
|August 29, 2023
Summary
Zwitterionic mesoporous engineering aids in identifying liver diseases like cirrhosis and cancer. This novel nanomedicine approach precisely distinguishes healthy and diseased states using key peptide biomarkers.
Area of Science:
- Biomedical Engineering
- Nanomedicine
- Analytical Chemistry
Background:
- Liver disease, including cirrhosis and cancer, presents a growing global health burden.
- Accurate and early diagnosis is crucial for effective patient management and treatment.
- Current diagnostic methods may lack the specificity or sensitivity required for early detection.
Purpose of the Study:
- To develop a novel zwitterionic mesoporous engineering approach for identifying liver diseases.
- To establish a sensitive and specific method for distinguishing between healthy and diseased liver states.
- To identify key peptide biomarkers indicative of liver cirrhosis and liver cancer.
Main Methods:
- Utilized zwitterionic mesoporous engineering for signal enrichment.
- Analyzed mass-to-charge (m/z) signals to identify potential biomarkers.
- Employed mass spectrometry to identify and validate key peptides associated with liver disease states.
Main Results:
- Enriched a total of 2633 m/z signals through the developed engineering approach.
- Identified three key peptides with high accuracy and precision.
- Demonstrated the capability of these peptides to effectively distinguish between healthy and diseased liver conditions.
Conclusions:
- Zwitterionic mesoporous engineering offers a promising platform for liver disease diagnostics.
- The identified peptide biomarkers hold potential for non-invasive and accurate disease detection.
- This advancement contributes to the field of nanomedicine and personalized liver disease management.
